Pura Vida Investments, LLC Sarepta Therapeutics, Inc. Transaction History

Pura Vida Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$62.69 - $88.44 $1.62 Million - $2.29 Million	-25,850 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $1.63 Million - $2.34 Million	25,850 New	25,850 $2.02 Million
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $1.84 Million - $2.58 Million	-16,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $1.15 Million - $2.46 Million	16,000 New	16,000 $2.12 Million
Q4 2017 Feb 14, 2018	SELL	$47.64 - $56.75 $2.38 Million - $2.84 Million	-50,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $1.79 Million - $2.36 Million	50,000	50,000 $2.27 Billion

525

84.4M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.96B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.